Content about Dextromethorphan

September 26, 2011

The U.S. Senate last week adopted a resolution designating the month of October 2011 as “National Medicine Abuse Awareness Month” to raise attention to the problem of prescription medicine abuse, especially by teenagers.

WASHINGTON — The U.S. Senate last week adopted a resolution designating the month of October 2011 as “National Medicine Abuse Awareness Month” to raise attention to the problem of prescription medicine abuse, especially by teenagers.

September 1, 2011

California on Wednesday banned the sale of dextromethorphan to minors, becoming the first state to pass such legislation.

SACRAMENTO, Calif. — California on Wednesday banned the sale of dextromethorphan to minors, becoming the first state to pass such legislation.

August 11, 2011

Drug maker Avanir Pharmaceuticals has filed suit against two generic drug makers seeking to launch versions of a drug used to treat pseudobulbar affect, which causes sudden, involuntary episodes of laughing and crying, and occurs secondary to numerous other neurological conditions.

ALISO VIEJO, Calif. — Drug maker Avanir Pharmaceuticals has filed suit against two generic drug makers seeking to launch versions of a drug used to treat pseudobulbar affect, which causes sudden, involuntary episodes of laughing and crying, and occurs secondary to numerous other neurological conditions.

Avanir filed the suit in the U.S. District Court for the District of Delaware against Par and Actavis, which had filed for regulatory approval of Nuedexta (dextromethorphan hydrobromide and quinidine sulfate).

March 28, 2011

The U.S. Pharmacopeial Convention last week announced that it is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients. Updated test methodologies are crucial to help counter economically motivated adulteration — in which less expensive and potentially harmful ingredients are substituted for genuine medicines or their ingredients — and also to address the challenge of impurities that may go undetected with older, nonspecific assays and tests.

ROCKVILLE, Md. — The U.S. Pharmacopeial Convention last week announced that it is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients. Updated test methodologies are crucial to help counter economically motivated adulteration — in which less expensive and potentially harmful ingredients are substituted for genuine medicines or their ingredients — and also to address the challenge of impurities that may go undetected with older, nonspecific assays and tests.

March 25, 2011

There are three issues involving over-the-counter medicines today that have put the industry on the defensive, and all involve the question of appropriate access. Drug Store News examined each.

1. FLEXIBLE SPENDING ACCOUNTS
The issue: The Patient Protection and Affordable Care Act required that FSA participants obtain a prescription for those OTCs incorporated into their health savings agenda.

March 2, 2011

The Food and Drug Administration has taken action against makers of prescription drugs for cough-cold and allergies that don’t have regulatory approval, the agency said Wednesday.

SILVER SPRING, Md. — The Food and Drug Administration has taken action against makers of prescription drugs for cough-cold and allergies that don’t have regulatory approval, the agency said Wednesday.

The action is part of the agency’s Unapproved Drugs Initiative, which seeks to remove from the market drugs that have not received approval. In many cases, the drugs were marketed before the FDA adopted its current regulatory standards.

February 10, 2011

Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

MORRISTOWN, N.J. — Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

October 10, 2010

While the fact that two Food and Drug Administration advisory committees collectively voted 15 opposed...

October 6, 2010

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Wednesday joined...

WASHINGTON The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Wednesday joined forces to kick off their annual National Medicine Abuse Awareness Month to raise awareness of the dangers of youth prescription and over-the-counter medicine abuse.

This initiative, annually held in October, features a coordinated and concentrated effort to educate parents and youth of the potential dangers associated with prescription and OTC medicine abuse.

September 16, 2010

While the advisory committee vote of 15 opposed and nine in favor of scheduling the...

WHAT IT MEANS AND WHY IT’S IMPORTANT While the advisory committee vote of 15 opposed and nine in favor of scheduling the all-too-common cough-relieving ingredient dextromethorphan as a controlled substance might seem like a healthy indicator as to which direction the Food and Drug Administration will act on this issue, make no mistake: it is by no means a certainty. This still may be an issue for cough-cold season 2011-2012.

September 14, 2010

A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the...

WASHINGTON A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the FDA not place greater sales restrictions on the sale of dextromethorphan by placing the ingredient on the controlled substances schedule. The panel of FDA advisers voted to not schedule DXM by a vote of 15-9.

 

September 13, 2010

As the Food and Drug Administration's Drug Safety and Risk Management Committee debated Tuesday on...

September 9, 2010

The Center for Medicine in the Public Interest on Thursday released the results of a...

August 31, 2010

The Food and Drug Administration last week issued an information packet in preparation for a...

SILVER SPRING, Md. The Food and Drug Administration last week issued an information packet in preparation for a Sept. 14 advisory committee meeting that will address the potential abuse of dextromethorphan products and whether restrictions should be placed on the sale of those over-the-counter cough medicines.

 

Members of both the FDA Drug Safety and Risk Management Advisory Committee and the FDA Nonprescription Drugs Advisory Committee will be in attendance at the public meeting.

 

 

June 6, 2010

The Food and Drug Administration will be re-evaluating the abuse potential of the cough-cold ingredient...

May 5, 2010

Perrigo on Wednesday announced that it has acquired the exclusive U.S. store brand rights to...

May 3, 2010

The Food and Drug Administration on Tuesday announced through the Federal Register that a Sept....

March 2, 2010

While there was no significant increase in the abuse of over-the-counter cough medicines containing dextromethorphan,...

February 4, 2010

A viral e-mail currently making the rounds between private accounts and public message boards warning...

December 20, 2009

Among teens, meth abuse is down and dextromethorphan abuse is not on the rise. That...

NEW YORK Among teens, meth abuse is down and dextromethorphan abuse is not on the rise. That suggests that efforts to curb teen drug abuse, no matter what the abused drug may be, is making some headway. But that also suggests there’s still a significant need to continue raising awareness around the dangers associated with abuse.

 

December 20, 2009

Consumers can be expected to self-identify a cough, and even locate a cough remedy in...

NEW YORK Consumers can be expected to self-identify a cough, and even locate a cough remedy in the nonprescription aisles. But consumers cannot be expected to distinguish between dextromethorphan and guaifenesin necessarily. Both are indicated for cough relief, but work in entirely different ways. For that you need a readily accessible healthcare professional, such as the pharmacist or nurse practitioner.

 

November 8, 2009

The ultimate impact in allowing local municipalities to regulate what’s prescription and what isn’t, will...

NEW YORK The ultimate impact in allowing local municipalities to regulate what’s prescription and what isn’t, will more than quadruple the price of nonprescription medicines, and not just decongestants. And that’s outrageous.

 

September 27, 2009

The greater awareness raised around the potential of abuse of drugs commonly stored in the...

NEW YORK The greater awareness raised around the potential of abuse of drugs commonly stored in the consumers’ medicine cabinets among teens, the greater chance of reducing that drug abuse.

 

According to surveys conducted on behalf of the Consumer Healthcare Products Association and others in the past, when a parent talks to their children about drug abuse, it reduces the chances that that child abuses drugs by some 50%.